CD19 Mouse Monoclonal Antibody [Clone ID: OTI3B10]
CAT#: TA506236M
CD19 mouse monoclonal antibody, clone OTI3B10
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 1350.00
货期*
                        现货
                    规格
                        Specifications
| Product Data | |
| Clone Name | OTI3B10 | 
| Applications | FC, IF, IHC, WB | 
| Recommend Dilution | WB 1:4000, IHC 1:150, IF 1:100 | 
| Reactivity | Human | 
| Host | Mouse | 
| Clonality | Monoclonal | 
| Immunogen | Full length human recombinant protein of human CD19(NP_001761) produced in HEK293T cell. | 
| Isotype | IgG1 | 
| Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. | 
| Concentration | 1 mg/ml | 
| Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) | 
| Conjugation | Unconjugated | 
| Storage Condition | Store at -20°C as received. | 
| Predicted Protein Size | 60.9 kDa | 
| Gene Name | CD19 molecule | 
| Database Link | |
| Background | Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq, Jul 2008] | 
| Synonyms | B4; CVID3 | 
| Reference Data | |
| Protein Families | Druggable Genome, Transmembrane | 
| Protein Pathways | B cell receptor signaling pathway, Hematopoietic cell lineage, Primary immunodeficiency | 
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        
 
	
 
                         
                             
                             
                             
                             
                             
                             
                             
                             
                             
        